Stocks and Investing Stocks and Investing
Wed, January 25, 2023
[ 12:00 AM ] - United States, WOPRAI
David Koning Maintained (WEX) at Buy with Increased Target to $200 on, Jan 25th, 2023
[ 12:00 AM ] - United States, WOPRAI
Austin Moeller Maintained (VSEC) at Strong Buy with Increased Target to $58 on, Jan 25th, 2023
[ 12:00 AM ] - United States, WOPRAI
Patrick Tyler Brown Maintained (VMC) at Buy with Increased Target to $199 on, Jan 25th, 2023
[ 12:00 AM ] - United States, WOPRAI
Lauren Schenk Maintained (WW) at Hold with Decreased Target to $3 on, Jan 25th, 2023
Tue, January 24, 2023
[ 12:00 AM ] - United States, WOPRAI
Nathan Jones Upgraded (XYL) to Strong Buy and Increased Target to $124 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Zachary Fadem Initiated (YUM) at Buy and Held Target at $145 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Andrew Kuske Upgraded (WFG) to Buy and Decreased Target to $95 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Essex Initiated (VRNS) at Sell and Held Target at $25 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Colin Isaac Downgraded (VMC) to Hold and Increased Target to $185 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (VRTX) at Hold with Increased Target to $286 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Julien Dumoulin-Smith Maintained (WEC) at Strong .. with Increased Target to $103 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Luke Sergott Maintained (WAT) at Buy with Increased Target to $380 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Manthey Maintained (WCC) at Hold with Increased Target to $170 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Hamilton Faber Maintained (WBD) at Buy and Held Target at $22 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jonathan Komp Downgraded (VFC) to Hold and Held Target at $34 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Devin McDermott Maintained (APA) at Hold with Decreased Target to $44 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Joseph Feldman Maintained (AMZN) at Buy with Decreased Target to $125 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Robert Burns Reiterated (ZYME) at Hold and Held Target at $8 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Essex Initiated (ZS) at Hold and Held Target at $124 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Manan Gosalia Maintained (ZION) at Hold with Decreased Target to $59 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Durgesh Chopra Downgraded (AEP) to Hold and Increased Target to $102 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (ADAG) at Buy with Decreased Target to $5 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (ADCT) at Hold with Decreased Target to $5 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Anthony Petrone Maintained (ABT) at Hold with Increased Target to $110 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Lloyd Walmsley Maintained (ABNB) at Hold with Increased Target to $114 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Lloyd Walmsley Maintained (BKNG) at Strong Buy on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Charles Minervino Maintained (BKR) at Buy with Increased Target to $40 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
James West Maintained (BKR) at Buy with Increased Target to $37 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Bryan Keane Maintained (BILL) at Strong Buy with Decreased Target to $150 on, Jan 24th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matthew Harrison Maintained (BMRN) at Buy with Increased Target to $132 on, Jan 24th, 2023

Matthew Harrison Maintained (BMRN) at Buy with Increased Target to $132 on, Jan 24th, 2023


Published on 2024-10-28 01:04:43 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $113 to $132 on, Jan 24th, 2023.

Matthew has made no other calls on BMRN in the last 4 months.



There are 7 other peers that have a rating on BMRN. Out of the 7 peers that are also analyzing BMRN, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Whitney Ijem of "Canaccord Genuity" Initiated at Hold and Held Target at $119 on, Wednesday, January 18th, 2023
  • Andreas Argyrides of "Wedbush" Maintained at Hold with Increased Target to $83 on, Wednesday, January 11th, 2023
  • Luca Issi of "RBC Capital" Maintained at Hold with Increased Target to $95 on, Thursday, October 13th, 2022


These are the ratings of the 4 analyists that currently disagree with Matthew

  • Akash Tewari of "Jefferies" Maintained at Strong Buy with Increased Target to $120 on, Tuesday, November 29th, 2022
  • Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Increased Target to $110 on, Monday, October 31st, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $110 on, Thursday, October 27th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $112 on, Monday, October 24th, 2022

Contributing Sources